Dee Mangin | Academic Influence

Dee Mangin's AcademicInfluence.com Rankings

Dee Mangin

Computer Science

#11133

World Rank

#11762

Historical Rank

Machine Learning

#5422

World Rank

#5493

Historical Rank

Artificial Intelligence

#5852

World Rank

#5941

Historical Rank

Database

#8160

World Rank

#8509

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Dee Mangin's Degrees

PhD Computer Science University of California, Berkeley
Masters Computer Science Stanford University

Similar Degrees You Can Earn

Why Is Dee Mangin Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Derelie Mangin is a New Zealand primary care academic. As of 2018, she is a full professor at the University of Otago and holds the David Braley Nancy Gordon Chair in Family Medicine at McMaster University.

(See a Problem?)

Dee Mangin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. (2010) (526)
Beyond diagnosis: rising to the multimorbidity challenge (2012) (151)
Challenges and Enablers of Deprescribing: A General Practitioner Perspective (2016) (138)
International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action (2018) (114)
Preventive health care in elderly people needs rethinking (2007) (113)
The Quality and Outcomes Framework: what have you done to yourselves? (2007) (98)
Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity (2016) (87)
Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. (2011) (67)
Clinical care and health disparities. (2012) (60)
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities (2019) (56)
General practitioners’ insight into deprescribing for the multimorbid older individual: a qualitative study (2016) (49)
Enduring sexual dysfunction after treatment with antidepressants, 5α-reductase inhibitors and isotretinoin: 300 cases (2018) (48)
Protocol for a Delphi consensus exercise to identify a core set of criteria for selecting health related outcome measures (HROM) to be used in primary health care (2018) (43)
Quality of Chronic Kidney Disease Management in Canadian Primary Care (2019) (43)
Prevalence of complementary and alternative medicine use in Christchurch, New Zealand: children attending general practice versus paediatric outpatients. (2007) (39)
One hundred and twenty cases of enduring sexual dysfunction following treatment. (2014) (37)
Deprescribing Is an Essential Part of Good Prescribing. (2019) (34)
A protocol for a pragmatic randomized controlled trial using the Health Teams Advancing Patient Experience: Strengthening Quality (Health TAPESTRY) platform approach to promote person-focused primary healthcare for older adults (2015) (33)
Maintenance or Discontinuation of Antidepressants in Primary Care. (2021) (33)
Prevalence and Demographics of CKD in Canadian Primary Care Practices: A Cross-sectional Study (2019) (32)
Multimorbidity, eHealth and implications for equity: a cross-sectional survey of patient perspectives on eHealth (2019) (32)
Multimorbidity Frameworks Impact Prevalence and Relationships with Patient‐Important Outcomes (2019) (31)
Combining volunteers and primary care teamwork to support health goals and needs of older adults: a pragmatic randomized controlled trial (2019) (30)
An international perspective on the basis for payment for performance. (2010) (29)
Legacy Drug-Prescribing Patterns in Primary Care (2018) (25)
Industry funded patient information and the slippery slope to New Zealand (2007) (24)
Chlamydia trachomatis Testing Sensitivity in Midstream Compared With First-Void Urine Specimens (2012) (24)
Self-efficacy for medication management: a systematic review of instruments (2018) (24)
Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities (2017) (21)
Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence. (2016) (19)
The comparative risk of new-onset diabetes after prescription of drugs for cardiovascular risk prevention in primary care: a national cohort study (2013) (19)
Disconnected relationships between primary care and community-based health and social services and system navigation for older adults: a qualitative descriptive study (2020) (17)
The ethics of randomized placebo controlled trials of antidepressants with pregnant women (2010) (17)
Diabetes care in rest homes in Christchurch, New Zealand (2006) (17)
A walking stick in one hand and a chainsaw in the other: patients' perspectives of living with multimorbidity. (2017) (16)
Clinical judgments, not algorithms, are key to patient safety—an essay by David Healy and Dee Mangin (2019) (15)
Pandemic influenza A(H1N1)pdm09: risk of infection in primary healthcare workers. (2013) (14)
Risk communication methods in hip fracture prevention: a randomised trial in primary care. (2011) (14)
Effect of multimorbidity on health service utilisation and health care experiences. (2018) (14)
The impact of advertising prescription medicines directly to consumers in New Zealand: lessons for Australia (2006) (14)
The once and future psychiatry. (2009) (13)
Examining Interprofessional teams structures and processes in the implementation of a primary care intervention (Health TAPESTRY) for older adults using normalization process theory (2020) (12)
Proposed new industry code on unhealthy food marketing to children and young people: will it make a difference? (2017) (12)
Direct-to-consumer advertising of prescription medicines: a counter argument. (2009) (12)
Multimorbidity and Quaternary Prevention (P4) (2015) (12)
A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised contro (2019) (11)
Feasibility study of goal setting discussions between older adults and volunteers facilitated by an eHealth application: development of the Health TAPESTRY approach (2018) (11)
Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin (2021) (11)
‘I think this medicine actually killed my wife’: patient and family perspectives on shared decision-making to optimize medications and safety (2019) (11)
Bedtime versus morning use of antihypertensives for cardiovascular risk reduction (BedMed): protocol for a prospective, randomised, open-label, blinded end-point pragmatic trial (2022) (11)
Does My Bias Look Big in This (2016) (11)
Urinary tract infection in primary care (2010) (10)
GeriMedRisk, a telemedicine geriatric pharmacology consultation service to address adverse drug events in long-term care: a stepped-wedge cluster randomized feasibility trial protocol (ISRCTN17219647) (2018) (10)
Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern? (2005) (10)
Perceptions of older adults in Ontario, Canada on the implementation and impact of a primary care programme, Health Teams Advancing Patient Experience: Strengthening Quality (Health TAPESTRY): a descriptive qualitative study (2019) (10)
Developing and testing an electronic medication administration monitoring device for community dwelling seniors: a feasibility study (2017) (10)
A national surveillance project on chronic kidney disease management in Canadian primary care: a study protocol (2017) (9)
Ninety-three cases of alcohol dependence following SSRI treatment. (2014) (9)
Health TAPESTRY Ontario: protocol for a randomized controlled trial to test reproducibility and implementation (2019) (9)
Adherence to evidence-based guidelines is the key to improved health outcomes for general practice patients: NO. (2012) (9)
Urinary tract infection in primary care (2007) (8)
Pill for this and a pill for that: A cross‐sectional survey of use and understanding of medication among adults with multimorbidity (2018) (8)
Clinical guidelines: what happens when people have multiple conditions? (2018) (8)
Post-SSRI sexual dysfunction: Patient experiences of engagement with healthcare professionals. (2019) (8)
Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use (2019) (7)
Do Residents Need All Their Medications? A Cross-Sectional Survey of RNs' Views on Deprescribing and the Role of Clinical Pharmacists. (2017) (7)
Strategies to Mitigate Anxiety and Pain in Intrauterine Device Insertion: A Systematic Review. (2019) (6)
A healthy lifestyle app for older adults with diabetes and hypertension: usability assessment (2017) (6)
Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis (2021) (6)
The shipwreck of the singular (2014) (6)
Machine learning for identification of frailty in Canadian primary care practices (2021) (6)
The impact of multimorbidity on people's lives: a cross-sectional survey. (2018) (5)
Horses and buggies have some advantages over cars, but no one is turning back. (2015) (5)
Pilot randomized controlled trial of a complex intervention for diabetes self-management supported by volunteers, technology, and interprofessional primary health care teams (2019) (5)
Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial (2021) (5)
Ethical issues related to health checks (2014) (5)
Nortriptyline in knee osteoarthritis (NortIKA Study): study protocol for a randomised controlled trial (2015) (5)
Exploration of volunteers as health connectors within a multicomponent primary care-based program supporting self-management of diabetes and hypertension. (2019) (4)
Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study (2021) (4)
Strategies for working across Canadian practice-based research and learning networks (PBRLNs) in primary care: focus on frailty (2021) (3)
Gabapentin misuse (2019) (3)
The art and science of marketing medications. (2015) (3)
Nortriptyline for pain in knee osteoarthritis: a double-blind randomised controlled trial in New Zealand general practice (2021) (3)
Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review (2022) (3)
Recommendations for outcome measurement for deprescribing intervention studies (2022) (3)
Nortriptyline for pain in knee osteoarthritis in general practice: a double blind randomised controlled trial. (2021) (3)
Evidence of net benefit is lacking (2007) (3)
Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis (2022) (3)
Demonstrating a Technology-Mediated Intervention to Support Medication Adherence in Community-Dwelling Older Adults in Primary Care: A Feasibility Study (2019) (3)
Data based medicine and clinical judgement. (2013) (3)
Development and persistence of patient-reported visual problems associated with serotonin reuptake inhibiting antidepressants. (2021) (3)
Interventions to address polypharmacy in older adults living with multimorbidity (2022) (3)
Lessons Learned Through Two Phases of Developing and Implementing a Technology Supporting Integrated Care: Case Study (2022) (3)
Paroxetine is associated with malformation during pregnancy (2011) (3)
Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT. (2021) (3)
Polypharmacy and medicine regimens in older adults in residential aged care. (2022) (3)
The future of national health systems. (2011) (2)
The implementation and validation of the NoMAD during a complex primary care intervention (2022) (2)
Sudden cardiac death & the Reverse Dodo Verdict. (2014) (2)
Embedding “Smart” Disease Coding Within Routine Electronic Medical Record Workflow: Prospective Single-Arm Trial (2019) (2)
Engaging general practice and patients with AusTAPER, a pharmacist facilitated web‐based deprescribing tool (2021) (2)
Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis. (2022) (2)
The use of inhaled corticosteroids in early-stage COVID-19 (2021) (2)
All people over 75 years with a five-year CVD risk of ≥15% should be treated with statins unless specifically contraindicated: no. (2010) (2)
Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation. (2022) (2)
Brief on Primary Care Part 1: The Roles of Primary Care Clinicians and Practices in the First Two Years of the COVID-19 Pandemic in Ontario (2022) (2)
Association between frailty, chronic conditions and socioeconomic status in community-dwelling older adults attending primary care: a cross-sectional study using practice-based research network data (2023) (2)
Quality and outcomes framework. Evidence of net benefit is lacking. (2007) (2)
Comparative risk of new-onset diabetes following commencement of antipsychotics in New Zealand: a population-based clustered multiple baseline time series design (2019) (1)
Community Volunteers and Primary Care Providers Supporting Older Adults in System Navigation: A Mixed Methods Study (2022) (1)
Direct-to-consumer genetic testing: letting the genie out of the bottle? (2012) (1)
Women should give informed consent before starting SSRIs (2009) (1)
Deprescribing Antidepressants in Older People - Breaking Up Can Be Hard to Do. (2021) (1)
Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study (2022) (1)
Brief on Primary Care Part 2: Factors Affecting Primary Care Capacity in Ontario for Pandemic Response and Recovery (2022) (1)
Understanding volunteer retention in a complex, community‐centred intervention: A mixed methods study in Ontario, Canada (2022) (1)
Can general practitioners provide effective cardiovascular disease (CVD) prevention? Dreams and realities of CVD prevention. (2011) (1)
CAN DEPRESCRIBING GIVE WHAT POLYPHARMACY HAS TAKEN AWAY? FEASIBILITY TRIAL IN RESIDENTIAL AGED CARE (2017) (1)
A dipstick clinical prediction rule modestly improved diagnostic precision in women with suspected urinary tract infection (2009) (1)
The impact of post-market regulatory safety advisories on patients, prescribers, and the healthcare system (2019) (1)
Delphi Consensus on Core Criteria Set Selecting Amongst Health-Related Outcome Measures (Hrom) in Primary Health Care. (2020) (1)
Understanding how context and culture in six communities can shape implementation of a complex intervention: a comparative case study (2022) (1)
Risky Business [Letter] (2010) (0)
EE214 Impact of Depression Relapse on Participant Quality of Life and Costs to the English NHS: Secondary Analysis from the Antler Study on Antidepressant Discontinuation in Well Patients in Primary Care (2022) (0)
citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): Study (2019) (0)
Promotion, Professional Practice and Patient Trust (2020) (0)
It is the lack of evidence of the NET benefit of the framework itself, not the evidence around individual indicators that is the issue (2017) (0)
DO MY PATIENTS NEED ALL THEIR MEDICINES? REGISTERED NURSES’ VIEWS ON DEPRESCRIBING. (2017) (0)
Management of uncertainty (2006) (0)
A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing (2023) (0)
A Primary Care Perspective on Prescribing for Women (2015) (0)
Highlights of the Canadian Frailty Network (CFN) Highly Qualified Personnel Poster Session (2019) (0)
For peer review only The comparative risk of new -onset diabetes after prescription of drugs for cardiovascular risk prevention in primary care: a national cohort study. (2013) (0)
Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trial. (2023) (0)
Family Medicine Forum Research Proceedings 2015 Toronto, Ont (2016) (0)
Limits to medicine (2017) (0)
Interventions to address potentially inappropriate prescriptions and over-the-counter medication use among adults 65 years and older in primary care settings: protocol for a systematic review (2022) (0)
I’M SURE I NEED THEM ALL: OLDER ADULTS EXPERIENCES OF POLYPHARMACY AND DEPRESCRIBING (2017) (0)
Brief on Primary Care Part 3: Lessons Learned for Strengthened Primary Care in the Next Phase of the COVID-19 Pandemic (2022) (0)
Review: Cranberry products do not reduce urinary tract infections in susceptible populations (2013) (0)
Health TAPESTRY Ontario: A Multi-Site Randomized Controlled Trial Testing Implementation and Reproducibility (2023) (0)
Asthma deaths and long acting beta agonists (2017) (0)
Should we give aspirins and statins to the elderly? (2009) (0)
To be successful or not to be: retrospective analysis of two deprescribing case studies (2019) (0)
Family Medicine Forum Research Proceedings 2016 Vancouver, BC (2017) (0)
The slippery slope to New Zealand (2007) (0)
To the Editor (2010) (0)
Abstracts: Scientific papers, education sessions to be presented at the May 26–28, 2016 Victoria, BC (2016) (0)
Error in paper may result in failure to warn. (2017) (0)
Risky business. (2010) (0)
Reducing Polypharmacy: Is Hospitalization the Right Time?—Reply (2011) (0)
Correction to: Cost-Utility Analysis of Discontinuing Antidepressants in England Primary Care Patients Compared with Long-Term Maintenance: The ANTLER Study (2021) (0)
Polypharmacy and mobility outcomes (2020) (0)
Democracy Now - Open Cities, World Cities: Contribution to 'La Nuit des Idées' (2017) (0)
One hundred and twenty cases of enduring sexual dysfunction following treatment 109 (0)
Workshop, Addressing the limits of medical practice. Wonca 2013 (2013) (0)

This paper list is powered by the following services:

Other Resources About Dee Mangin

en.wikipedia.org

What Schools Are Affiliated With Dee Mangin?

Dee Mangin is affiliated with the following schools: